Nuveen »

Ocuphire Pharma shares owned by Nuveen

Quarter-by-quarter ownership of Ocuphire Pharma (IRD) shares owned by Nuveen from 13F filings

Historical chart of Nuveen investment in Ocuphire Pharma

Tip: Access up to 7 years of quarterly data

All positions including Ocuphire Pharma held by Nuveen consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ocuphire Pharma by Nuveen

Quarter filed Position value Share count Share price at filing
2026-06-30 $293k 71k 4.11

More positions owned by Nuveen

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Broadcom (AVGO)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Micron Technology (MU)
Applied Materials (AMAT)
Lam Research Corp Com New (LRCX)
Advanced Micro Devices (AMD)

View all positions for Nuveen

Top funds holding Ocuphire Pharma

Caligan Partners
Adage Capital Partners GP
BIOS Capital Management
BlackRock
Balyasny Asset Management
Nantahala Capital Management
Vanguard Capital Management
Boxer Capital Management
Trails Edge Capital Partners
Millennium Management
Dr. Jeffrey R. Jay, M.D.
Marshall Wace
ADAR1 Capital Management
Goldman Sachs Group
Woodline Partners

View all funds holding Ocuphire Pharma